AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Worel, N Greinix, H Ackermann, J Kaufmann, H Urbauer, E Hocker, P Gisslinger, H Lechner, K Kalhs, P Drach, J
Citation: N. Worel et al., Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma, ANN HEMATOL, 80(6), 2001, pp. 345-348

Authors: Keil, F Prinz, F Kalhs, P Lechner, K Moser, K Schwarzinger, I Jager, U Fonatsch, C Worel, N Mannhalter, C Rabitsch, W Loidolt, H Schulenburg, A Mitterbauer, M Hocker, P Greinix, HT
Citation: F. Keil et al., Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants, LEUKEMIA, 15(3), 2001, pp. 355-361

Authors: Dettke, M Greinix, HT Kalhs, P Kuhrer, I Worel, N Hocker, P
Citation: M. Dettke et al., Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimaltiming of PBPC harvest, TRANSFUSION, 41(5), 2001, pp. 681-686

Authors: Worel, N Kurz, M Peters, C Hocker, P
Citation: N. Worel et al., Serial granulocytapheresis under daily administration of rHuG-CSF: effectson peripheral blood counts, collection efficiency, and yield, TRANSFUSION, 41(3), 2001, pp. 390-395

Authors: Keil, F Mitterbauer, G Chen, X Haas, OA Kalhs, P Lechner, K Mannhalter, C Moser, K Worel, N Pirc-Danoewinata, H Louda, N Loidolt, H Rabitsch, W Greinix, HT
Citation: F. Keil et al., PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR, TRANSFUSION, 41(1), 2001, pp. 111-116

Authors: Reiter, E Greinix, H Rabitsch, W Keil, F Schwarzinger, I Jaeger, U Lechner, K Worel, N Streubel, B Fonatsch, C Mitterbauer, G Kalhs, P
Citation: E. Reiter et al., Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q-21q26) or homologous translocation t(3;3) (q21;q26), ANN HEMATOL, 79(7), 2000, pp. 374-377

Authors: Schulenburg, A Kalhs, P Worel, N Hocker, P Knobl, P Greinix, HT
Citation: A. Schulenburg et al., Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases, BONE MAR TR, 25(2), 2000, pp. 223-224

Authors: Worel, N Greinix, HT Schneider, B Kurz, M Rabitsch, W Knobl, P Reiter, E Derfler, K Fischer, G Hinterberger, W Hocker, P Kalhs, P
Citation: N. Worel et al., Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems, TRANSFUSION, 40(5), 2000, pp. 543-550

Authors: Keil, F Kalhs, P Chen, X Haas, OA Fritsch, G Chott, A Lechner, K Moser, K Ackermann, J Rabitsch, W Worel, N Mannhalter, C Greinix, HT
Citation: F. Keil et al., Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation, ANN HEMATOL, 78(8), 1999, pp. 376-379

Authors: Reiter, E Kalhs, P Keil, F Rabitsch, W Gisslinger, H Mayer, G Worel, N Lechner, K Greinix, HT
Citation: E. Reiter et al., Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature, ANN HEMATOL, 78(4), 1999, pp. 189-191

Authors: Reiter, E Greinix, HT Keil, F Brugger, S Rabitsch, W Schulenburg, A Mannhalter, C Schwarzinger, I Worel, N Volc-Platzer, B Fischer, G Dieckmann, K Hinterberger, W Schneider, B Haas, OA Geissler, K Kalhs, P
Citation: E. Reiter et al., Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia, ANN HEMATOL, 78(11), 1999, pp. 507-513

Authors: Peters, C Minkov, M Matthes-Martin, S Potschger, U Witt, V Mann, G Hocker, P Worel, N Stary, J Klingebiel, T Gadner, H
Citation: C. Peters et al., Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients, BR J HAEM, 106(3), 1999, pp. 689-696

Authors: Reiter, E Greinix, HT Mitterbauer, G Fischer, G Keil, F Mannhalter, C Rabitsch, W Schwarzinger, I Worel, N Lechner, K Kalhs, P
Citation: E. Reiter et al., Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia, ANN HEMATOL, 77(6), 1998, pp. 283-286
Risultati: 1-13 |